Pranav Oberoi

743 total citations
14 papers, 540 citations indexed

About

Pranav Oberoi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Pranav Oberoi has authored 14 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Pranav Oberoi's work include CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (4 papers). Pranav Oberoi is often cited by papers focused on CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (4 papers). Pranav Oberoi collaborates with scholars based in Germany, India and Israel. Pranav Oberoi's co-authors include Winfried S. Wels, Anja Waldmann, Congcong Zhang, Sarah Oelsner, Torsten Tonn, Robert A. Jabulowsky, Jasmin Röder, Hayat Bähr-Mahmud, Malena Bodden and Benjamin Dälken and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Cancer.

In The Last Decade

Pranav Oberoi

14 papers receiving 529 citations

Peers

Pranav Oberoi
Ranjan Upadhyay United States
Kathryn Ruisaard United States
Ryan Bjordahl United States
Tamara Laskowski United States
Sarah Oelsner Germany
Anja Waldmann Germany
Kevin M. Friedman United States
James Dongjoo Ham United States
Marine Cazaux France
Diana Campillo-Davó Belgium
Ranjan Upadhyay United States
Pranav Oberoi
Citations per year, relative to Pranav Oberoi Pranav Oberoi (= 1×) peers Ranjan Upadhyay

Countries citing papers authored by Pranav Oberoi

Since Specialization
Citations

This map shows the geographic impact of Pranav Oberoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pranav Oberoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pranav Oberoi more than expected).

Fields of papers citing papers by Pranav Oberoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pranav Oberoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pranav Oberoi. The network helps show where Pranav Oberoi may publish in the future.

Co-authorship network of co-authors of Pranav Oberoi

This figure shows the co-authorship network connecting the top 25 collaborators of Pranav Oberoi. A scholar is included among the top collaborators of Pranav Oberoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pranav Oberoi. Pranav Oberoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Oberoi, Pranav, et al.. (2024). Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies. Frontiers in Immunology. 15. 1457887–1457887. 3 indexed citations
2.
3.
Zhang, Congcong, Pranav Oberoi, Malena Bodden, et al.. (2023). Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers. Cancer Immunology Immunotherapy. 72(9). 2905–2918. 5 indexed citations
4.
Zhang, Congcong, Jasmin Röder, Anne Scherer, et al.. (2021). Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity. Journal for ImmunoTherapy of Cancer. 9(10). e002980–e002980. 48 indexed citations
5.
6.
Oelsner, Sarah, Anja Waldmann, Jasmin Röder, et al.. (2019). Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth. International Journal of Cancer. 145(7). 1935–1945. 71 indexed citations
7.
Zhang, Congcong, Pranav Oberoi, Sarah Oelsner, et al.. (2017). Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity. Frontiers in Immunology. 8. 533–533. 258 indexed citations
8.
Oberoi, Pranav & Winfried S. Wels. (2013). Arming NK cells with enhanced antitumor activity. OncoImmunology. 2(8). e25220–e25220. 21 indexed citations
9.
Oberoi, Pranav, Robert A. Jabulowsky, Hayat Bähr-Mahmud, & Winfried S. Wels. (2013). EGFR-Targeted Granzyme B Expressed in NK Cells Enhances Natural Cytotoxicity and Mediates Specific Killing of Tumor Cells. PLoS ONE. 8(4). e61267–e61267. 27 indexed citations
10.
Oberoi, Pranav, Robert A. Jabulowsky, & Winfried S. Wels. (2013). Selective Induction of Cancer Cell Death by Targeted Granzyme B. SHILAP Revista de lepidopterología. 2(1). 130–151. 6 indexed citations
11.
Jabulowsky, Robert A., Pranav Oberoi, Hayat Bähr-Mahmud, Benjamin Dälken, & Winfried S. Wels. (2012). Surface Charge-Modification Prevents Sequestration and Enhances Tumor-Cell Specificity of a Recombinant Granzyme B–TGFα Fusion Protein. Bioconjugate Chemistry. 23(8). 1567–1576. 13 indexed citations
12.
Dälken, Benjamin, Robert A. Jabulowsky, Pranav Oberoi, Itai Benhar, & Winfried S. Wels. (2010). Maltose-Binding Protein Enhances Secretion of Recombinant Human Granzyme B Accompanied by In Vivo Processing of a Precursor MBP Fusion Protein. PLoS ONE. 5(12). e14404–e14404. 15 indexed citations
13.
Madhavan, Jagadeesan, Mallikarjuna Kandalam, Pranav Oberoi, et al.. (2009). KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.. PubMed. 15. 235–40. 28 indexed citations
14.
Swain, Prabodha K., et al.. (2007). Mutations associated with retinopathies alter mitogen-activated protein kinase-induced phosphorylation of neural retina leucine-zipper.. PubMed. 13. 1114–20. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ranjan Upadhyay Breakdown of academic impact, for papers by Kathryn Ruisaard Breakdown of academic impact, for papers by Ryan Bjordahl Breakdown of academic impact, for papers by Tamara Laskowski Breakdown of academic impact, for papers by Sarah Oelsner Breakdown of academic impact, for papers by Anja Waldmann Breakdown of academic impact, for papers by Kevin M. Friedman Breakdown of academic impact, for papers by James Dongjoo Ham Breakdown of academic impact, for papers by Marine Cazaux Breakdown of academic impact, for papers by Diana Campillo-Davó
Rankless by CCL
2026